4/25
07:12 am
hrtx
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook [Yahoo! Finance]
Medium
Report
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook [Yahoo! Finance]
4/24
08:07 am
hrtx
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 [Yahoo! Finance]
High
Report
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 [Yahoo! Finance]
4/24
08:00 am
hrtx
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Medium
Report
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
4/23
07:02 am
hrtx
Heron Therapeutics, Inc. (NASDAQ: HRTX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $6.00 price target on the stock.
Medium
Report
Heron Therapeutics, Inc. (NASDAQ: HRTX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $6.00 price target on the stock.
4/16
04:58 pm
hrtx
Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain [Seeking Alpha]
Medium
Report
Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain [Seeking Alpha]
4/11
04:08 pm
hrtx
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City [Yahoo! Finance]
Low
Report
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City [Yahoo! Finance]
4/11
04:05 pm
hrtx
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Low
Report
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
4/11
08:06 am
hrtx
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
High
Report
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
4/2
09:29 am
hrtx
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer [Yahoo! Finance]
Medium
Report
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer [Yahoo! Finance]
3/28
04:19 pm
hrtx
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Neutral
Report
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
3/28
04:05 pm
hrtx
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
3/13
09:36 am
hrtx
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
High
Report
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/13
08:16 am
hrtx
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target raised by analysts at Needham & Company LLC from $4.00 to $5.00. They now have a "buy" rating on the stock.
High
Report
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target raised by analysts at Needham & Company LLC from $4.00 to $5.00. They now have a "buy" rating on the stock.
3/12
07:22 pm
hrtx
Compared to Estimates, Heron Therapeutics (HRTX) Q4 Earnings: A Look at Key Metrics [Yahoo! Finance]
High
Report
Compared to Estimates, Heron Therapeutics (HRTX) Q4 Earnings: A Look at Key Metrics [Yahoo! Finance]
3/12
04:15 pm
hrtx
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates [Yahoo! Finance]
High
Report
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates [Yahoo! Finance]
3/12
04:05 pm
hrtx
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
High
Report
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
3/11
07:25 pm
hrtx
United States Anesthesia Drugs Research Report 2024: A $3.29 Billion Market by 2030, Driven by Elevated Product Launches, Strategic Acquisitions, and Government Approvals [Yahoo! Finance]
Medium
Report
United States Anesthesia Drugs Research Report 2024: A $3.29 Billion Market by 2030, Driven by Elevated Product Launches, Strategic Acquisitions, and Government Approvals [Yahoo! Finance]
3/7
10:50 am
hrtx
Curious about Heron Therapeutics (HRTX) Q4 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Curious about Heron Therapeutics (HRTX) Q4 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]
2/28
08:14 am
hrtx
Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024 [Yahoo! Finance]
Low
Report
Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024 [Yahoo! Finance]
2/28
08:00 am
hrtx
Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
Low
Report
Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
2/16
05:35 am
hrtx
Investors in Heron Therapeutics (NASDAQ:HRTX) from five years ago are still down 90%, even after 23% gain this past week [Yahoo! Finance]
Low
Report
Investors in Heron Therapeutics (NASDAQ:HRTX) from five years ago are still down 90%, even after 23% gain this past week [Yahoo! Finance]
2/6
01:35 pm
hrtx
All You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Strong Buy [Yahoo! Finance]
Low
Report
All You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Strong Buy [Yahoo! Finance]